Abstracts from the 2024 WDS Forum - Virtual Option

    TLDR 5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.
    The document summarizes multiple studies presented at the 2024 WDS Forum. A retrospective cohort study involving 37,078 female alopecia patients found no increased risk of gynecological tumors with 5-alpha reductase inhibitors or spironolactone compared to minoxidil. Another study indicated an increased risk of new-onset alopecia with glucagon-like-peptide-1 receptor agonists. Research highlighted a correlation between sanitary pad use and dermatitis, and emphasized early intervention for hidradenitis suppurativa in Hispanic patients. A pilot study in Massachusetts showed community-based education improved skin cancer prevention awareness. Additional studies found metformin associated with higher survival rates in certain skin cancers, increased acne risk with LNG-IUDs, high accuracy of machine learning in basal cell carcinoma detection, and a higher risk of spontaneous abortion with JAK-inhibitors during pregnancy. Lastly, inclusivity in skincare advertising was found to influence individuals with darker skin tones, and a study on CCCA in Black women suggested potential autoimmune involvement.
    Discuss this study in the Community →